The capacity and scope of our Trials Delivery programme, increased activity at our Data Portal and an extension of our Experimental Medicine work to scalable biomarkers all illustrate why rapid change is everywhere at DPUK.
There are looming challenges and opportunities with AI. Our Swansea team is engaged in assessing risks around research in secure Trusted Research Environments and AI-led trust by design solutions for privacy protection.
The focus within dementia research on blood biomarkers has also brought additional funding to DPUK from the Blood Biomarker Challenge to identify the utility of biomarkers and their cost-effective use in the NHS.
In this year's report, we have significant insights from people across the landscape including Professor David Bennett at Rush University in Chicago. Everywhere there is positive optimism about collaboration and partnerships.
Download a copy of the report. We hope you will enjoy reading it.